JUPITER NEUROSCIENCES, INC. Investment Income, Interest
JUPITER NEUROSCIENCES, INC. (JUNS) reported Investment Income, Interest of $10.07 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. investment income, interest for the quarter ending 2026-06-30 was $10.07K, a 22.85% decline year-over-year.
- JUPITER NEUROSCIENCES, INC. investment income, interest for the quarter ending 2026-03-31 was $18.40K, a 77.56% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. investment income, interest for the quarter ending 2025-09-30 was $10.21K, a 44300.00% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. investment income, interest for the quarter ending 2025-06-30 was $13.05K, a 24522.64% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. investment income, interest for fiscal 2024 was $5.56K, a 1052.90% increase from fiscal 2023.
- JUPITER NEUROSCIENCES, INC. investment income, interest for fiscal 2023 was $482.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.07K 10-Q · filed 2026-08-14 | $28.47K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $18.40K 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | $10.21K 10-Q · filed 2025-11-14 | $23.26K derived: sum of 2 quarters · filed 2026-08-14 | $33.63K 10-Q · filed 2025-11-14 | $39.05K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $13.05K 10-Q · filed 2026-08-14 | $23.41K 10-Q · filed 2026-08-14 | $28.83K derived: sum of 3 quarters · filed 2026-08-14 | $28.86K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $10.37K 10-Q · filed 2026-05-14 | $15.78K derived: sum of 2 quarters · filed 2026-05-14 | $15.81K derived: sum of 3 quarters · filed 2026-05-14 | $15.86K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $5.44K derived: sum of 2 quarters · filed 2026-04-01 | $5.50K derived: sum of 3 quarters · filed 2026-04-01 | $5.56K 10-K · filed 2026-04-01 |
| 2024-09-30 | $23.00 10-Q · filed 2025-11-14 | $76.00 derived: sum of 2 quarters · filed 2025-11-14 | $138.00 10-Q · filed 2025-11-14 | -$44.19K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $53.00 10-Q · filed 2025-08-19 | $115.00 10-Q · filed 2025-08-19 | -$44.21K derived: sum of 3 quarters · filed 2025-08-19 | -$44.05K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $62.00 10-Q · filed 2025-05-15 | -$44.27K derived: sum of 2 quarters · filed 2025-05-15 | -$44.11K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$44.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$44.17K derived: sum of 2 quarters · filed 2025-03-28 | $482.00 10-K · filed 2025-03-28 | |
| 2023-09-30 | $161.00 10-Q · filed 2024-12-23 | $44.81K 10-Q · filed 2024-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |